Novartis AG (NYSE:NVS) Renal Portfolio Update Conference Call October 28, 2024 8:00 AM ET Company Participants: Sloan Simpson – Head, Investor Relations Shreeram Aradhye – President, Global Drug Development and CMO Victor Bulto – President, U.S. Business Dave Soergel – Executive Vice President, Global Head, Cardio, Renal, Metabolic Development Conference Call Participants: Peter Welford –…
Axsome’s AXS-05: A Promising Development in Alzheimer’s Disease Agitation Treatment Axsome Therapeutics, a clinical-stage biopharmaceutical company, has recently announced its plans to submit a supplemental New Drug Application (sNDA) to the Food and Drug Administration (FDA) for AXS-05 in the treatment of Alzheimer’s disease agitation in the third quarter of 2025. This news comes as…
Recent Progress in Pediatric Clinical Trials: Achieving Safe Drug Concentrations in Infants In the ever-evolving landscape of pharmaceutical research, the wellbeing of all participants, particularly the most vulnerable, remains a top priority. Recently, a significant milestone was reached in a clinical trial involving open-label arm participants under the age of one. The Data Monitoring Committee…
Oversold PEPE: A Meme Coin’s Rollercoaster Ride The recent crypto market downturn Oh boy, buckle up crypto enthusiasts, because things are getting wild in the market! The recent downturn that has swept across the entire crypto market has left many investors scratching their heads and wondering what’s next. But amidst all the chaos, one meme…
Welcome to the World of Nexo Card Expansion! What’s the Buzz About? Did you hear the news? Nexo (NEXO), a digital assets wealth platform, is expanding its Nexo Card to more European markets, including Switzerland and Andorra. This exciting development was disclosed to Finbold on Tuesday, February 11, and has crypto enthusiasts buzzing with anticipation….
PostNL’s Subdued 2025 Forecast: A Challenging Market and Unpredictable Client Concentration PostNL, the Dutch postal operator, recently announced a subdued forecast for its two main divisions, PostNL Parcels & Logistics and PostNL Mail, for the year 2025. The company attributed this forecast to a challenging market and unpredictable client concentration due to changing consumer behaviour….
Occidental Petroleum Beats Expectations with Strong Quarterly Earnings Quarterly Earnings Report Occidental Petroleum (OXY) recently announced their quarterly earnings of $0.80 per share, surpassing the Zacks Consensus Estimate of $0.67 per share. This marks a significant increase from the $0.74 per share earnings reported in the same quarter last year. Financial Performance The impressive earnings…
Idorsia Ltd Reports 2024 Financial Results: A Detailed Analysis On March 4, 2025, Idorsia Ltd, a leading biopharmaceutical company based in Allschwil, Switzerland, announced its financial results for the year 2024. The company’s shares (SIX: IDIA) have been a topic of interest for investors due to its ongoing research and development efforts in the field…
